Core Viewpoint - Zhejiang province is undergoing a significant transformation in its pharmaceutical industry regulatory and service models, aiming to create an optimal business environment characterized by "best service, lowest cost, and highest efficiency" by 2026 [1][2]. Group 1: Regulatory and Service Model Changes - The province has outlined a path focused on checklist-based initiatives, integrated reforms, and precise services to enhance the pharmaceutical sector [1][2]. - Key reforms include the establishment of a detailed implementation checklist to ensure that policy benefits reach enterprises directly [2]. - The province aims to reduce the burden on companies by promoting a regulatory approach that allows for multiple checks in a single visit, targeting a reduction of over 20% in the time and manpower costs associated with on-site inspections [2]. Group 2: Industry Development and Competitive Advantage - Zhejiang's pharmaceutical industry has shown significant growth, with 12 companies ranked among China's top 100 pharmaceutical manufacturers, placing the province second nationally [2]. - The province is home to 91 publicly listed pharmaceutical companies, the highest in the country, and is the only region with a billion-dollar cosmetics enterprise [2]. - The focus on integrated reforms and the establishment of a collaborative policy framework aims to leverage these competitive advantages and further enhance the industry's development potential [2][3]. Group 3: Targeted Support and Resource Allocation - The province is implementing a "precision drip irrigation" approach to service delivery, particularly targeting underdeveloped areas and specialized industrial parks [3]. - By integrating regulatory and technical resources, Zhejiang aims to address regional disparities in innovation resources and foster distinctive local industrial clusters [3]. - The initiative includes forming specialized service teams to provide tailored policy guidance and technical support to meet specific regional needs [3].
“清单+集成+精准”浙江三招齐发优化医药营商环境
Zhong Guo Xin Wen Wang·2026-01-11 02:07